Alessandro Baldi, Ph.D. has joined Protea Biosciences Group as vice president and general manager. Dr. Baldi will be responsible for the management of the company’s bioanalytics products and services, including the company’s LAESI instrument technology.

Dr. Baldi has more than 25 years of experience in separation sciences and mass spectrometry. Before joining the company, he conducted research in natural products chemistry, and founded a consulting firm that worked with large Pharma and Energy companies in Europe and the Middle East. He joined PerkinElmer in the U.S. in 2001 and held senior roles as technology manager as well as business manager for its chromatography portfolio, before becoming senior director of the mass spectrometry business.

“We are delighted to have Dr. Baldi joining us,” said Steve Turner, Protea’s chief executive officer. “He is a leader in our industry, who possesses both strong technical and management experience, and has extensive overseas knowledge. Dr. Baldi is ideally suited to grow Protea’s bioanalytics business.”